These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9403359)

  • 21. [Therapeutic strategies in menstrual migraine].
    Targa C; Massons J
    Rev Neurol; 1995; 23 Suppl 2():S226-31. PubMed ID: 7497293
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ergotamine and methysergide as serotonin partial agonists in migraine.
    Fanciullacci M; Granchi G; Sicuteri F
    Headache; 1976 Nov; 16(5):226-31. PubMed ID: 977328
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of subcutaneous sumatriptan on head temperature in migraines.
    Parrinello G; Paterna S; Di Pasquale P; Pinto A; Cardinale A; Maniscalchi T; Cottone C; Follone G; Tuttolomondo A; Bologna P; Colomba D; D'Angelo A; Ortoleva A; Garofalo L; Piovana G; Capodieci E; Bova A; Giubilato A; Licata G
    Drugs Exp Clin Res; 1998; 24(4):197-205. PubMed ID: 10051966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of sumatriptan in the treatment of migraine.
    Gross M
    Br J Clin Pract; 1993; 47(4):205-7. PubMed ID: 8260340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current treatment of migraine].
    Liaño H
    Rev Clin Esp; 1992 Jul; 191(3):161-5. PubMed ID: 1323868
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
    Peroutka SJ
    Neurology; 1993 Jun; 43(6 Suppl 3):S34-8. PubMed ID: 8389009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Headache currents commentary.
    Peatfield R
    Headache; 2012 Apr; 52(4):715. PubMed ID: 22414189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
    Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
    J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan.
    Mehrotra S; Vanmolkot KR; Frants RR; van den Maagdenberg AM; Ferrari MD; MaassenVanDenBrink A
    Headache; 2007 May; 47(5):711-6. PubMed ID: 17501853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
    Antonatos S; Galanopoulou P
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of 5-hydroxytryptamine receptors in human temporal arteries: comparison between migraine suffers and nonsufferers.
    Skärby T; Tfelt-Hansen P; Gjerris F; Edvinsson L; Olesen J
    Ann Neurol; 1982 Sep; 12(3):272-7. PubMed ID: 7137963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
    Diener HC; Peters C; Rudzio M; Noe A; Dichgans J; Haux R; Ehrmann R; Tfelt-Hansen P
    J Neurol; 1991 Aug; 238(5):245-50. PubMed ID: 1655985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects.
    Hilton BP; Zilkha KJ
    J Neurol Neurosurg Psychiatry; 1974 May; 37(5):593-7. PubMed ID: 4836755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonists and antagonists of vascular receptors.
    Saxena PR
    Adv Neurol; 1982; 33():309-14. PubMed ID: 7034489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.